Thu. Sep 29th, 2022
WHO Solidarity trial finds Remdesivir has no substantial effect on mortality in COVID-19 patients The results of the Solidarity trial conducted on 11,266 hospitalised patients in 30 countries found remdesivir, along with three other repurposed drugs hydroxychloroquine, lopinavir/ritonavir and interferon to have little or no effect on 28-day mortality.